ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver grafts"

  • 2020 American Transplant Congress

    The Impact of Non-Directed Anonymous Live Liver Donors on the Number of Children on the Waitlist at a Single Pediatric Liver Transplant Center

    D. Yoeli1, M. A. Adams1, M. E. Wachs1, S. S. Sundaram2, R. A. Choudhury1, K. D. Conzen1, J. R. Burton3, E. A. Pomfret1, W. E. Jackson3

    1Transplant Surgery, University of Colorado, Aurora, CO, 2Pediatric Hepatology, University of Colorado, Aurora, CO, 3Transplant Hepatology, University of Colorado, Aurora, CO

    *Purpose: Since the initiation of our living donor (LD) pediatric liver transplant program in November 2016, 10 non-directed anonymous donors have been approved and completed…
  • 2020 American Transplant Congress

    Patients in Donor Service Areas with Higher Median MELD at Transplant Have a Lower Probability of Liver Transplant Waitlist Activation

    J. Merola1, S. Noreen2, D. Stewart2, R. Batra1, D. Haakinson1, G. Gan3, Y. Deng3, S. Kulkarni1

    1Yale School of Medicine, New Haven, CT, 2United Network of Organ Sharing, Richmond, VA, 3Yale Center for Analytical Sciences, Yale University, New Haven, CT

    *Purpose: US allocation of hepatic allografts is prioritized based on medical need, however significant geographical disparities exist with median MELD at transplant across donor specific…
  • 2020 American Transplant Congress

    Development and Characterization of Decellularized Whole Human Livers for Increasing Donor Pool

    A. Acun, R. Oganesyan, B. E. Uygun

    Massachusetts General Hospital - Harvard Medical School, Boston, MA

    *Purpose: Liver diseases are recognized as the second leading cause of mortality amongst all digestive diseases in the United States. Orthotopic liver transplantation leads to…
  • 2020 American Transplant Congress

    Adult Living Donor Liver Transplantation Results in Superior Patient and Graft Survival When Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis

    A. Barbetta1, M. Aljehani2, M. KIM1, C. Tien3, A. Ahearn1, H. Schilperoort2, L. Sher1, J. Emamaullee1

    1Surgery, abdominal transplat, University of Southern California, Los Angeles, CA, 2University of Southern California, Los Angeles, CA, 3Surgery, abdominal transplat, Keck Medical School, University of Southern California, Los Angeles, CA

    *Purpose: Center-specific or national registry studies have shown that living donor liver transplantation (LDLT) decreases waitlist mortality, reduces waiting time, and may offer superior patient…
  • 2020 American Transplant Congress

    Impact of the Baseline Anti-A/B IgG Titer on the Clinical Outcome in ABO-Incompatible Liver Transplantation

    J. Lee1, E. Kim1, S. Yang1, D. Kim2, M. Ju3, J. Lee1, M. Kim1, S. Kim1, D. Joo1

    1Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, 2Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of, 3Department of Surgery, Gangam Severance Hospital, Seoul, Korea, Republic of

    *Purpose: The use of ABO incompatible (ABOi) living donors is an attractive solution for expanding the liver donor pool. We investigated the impact of the…
  • 2020 American Transplant Congress

    Humanized Mouse Reveals the Cytoprotective Function of Hepatocyte RXFP1 in Liver Transplant Recipients

    H. Kojima1, S. Kageyama1, K. Kadono1, H. Hirao1, K. J. Dery1, T. Ito1, G. Sugahara2, Y. Ishida2, T. Saito2, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

    1Surgery, The Dumont-UCLA Transplantation Center, Los Angeles, CA, 2Division of Gastrointestinal and Liver Disease, Keck School of Medicine, USC, Los Angeles, CA

    *Purpose: RXFP1 (RLX family peptide receptor 1) is a cognate receptor for relaxin (RLX), an insulin-like growth factor, with vasoactive/remodeling properties. We have documented cytoprotective…
  • 2020 American Transplant Congress

    Human Live Donor Liver Transplantation is Associated with Pd-l1 Expression on Donor-Exosome-Acquiring Host Dendritic Cells

    D. Lema, E. Jankowska-Gan, D. Al-Adra, W. Burlingham

    Surgery- Transplantation, University of Wisconsin-Madison, Madison, WI

    *Purpose: Liver transplantation (LTx) has been associated with the phenomenon of “cross-dressing” of recipient dendritic cells (DCs) by donor exosome-derived MHC antigens, and acquisition of…
  • 2020 American Transplant Congress

    Factors Predicting Outcome after Living Donor Liver Transplantation in the Era of Intra-Operative Flow Measurements and Inflow Modulation

    D. Sonbare, D. Jorgensen, A. Humar

    University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: To identify pre/intra-operative factors which predict adverse outcome after living donor liver transplantation (LDLT).*Methods: All patients who underwent first LDLT at UPMC, Pittsburgh from…
  • 2020 American Transplant Congress

    Impact of UNOS Acceptance Sequence Number on Liver Graft Survival

    C. Thornley, O. Kezirian, S. Mehta, J. Cashman, J. Brink, T. Chaly Jr, W. Van der Werf

    University of Arizona/Banner University Medical Center Phoenix, Phoenix, AZ

    *Purpose: Many initially declined liver grafts will go on to be successfully transplanted into other candidates. Limited information exists regarding outcomes of liver grafts that…
  • 2020 American Transplant Congress

    Liver Transplant with Donation after Cardiac Death versus Donation after Brain Death Donors: Survival and Outcomes at 10 Years

    O. Haque1, E. Roth2, A. Fleishman1, K. Khwaja1

    1Surgery, Beth Israel Deaconess Medical Center, Boston, MA, 2Harvard Medical School, Boston, MA

    *Purpose: This observational study utilizes the SRTR database to assess liver transplant outcomes after Donation after Cardiac Death (DCD) versus Donation after Brain Death (DBD)…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences